πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 101 of 200 Β· A–Z by INN

  1. iop-lowering

    NMPA: clinical trials

  2. iopamidol

    IOPAMIDOL

    INJECTION FDA: approved

  3. iopanoic acid

    TELEPAQUE

    ORAL FDA: approved

  4. iophendylate

    PANTOPAQUE

    INJECTION FDA: approved

  5. iopromide

    ULTRAVIST (PHARMACY BULK)

    INJECTION FDA: approved

  6. iothalamate meglumine

    VASCORAY

    INTRAVESICAL, URETERAL FDA: approved

  7. iothalamate sodium

    ANGIO-CONRAY

    INJECTION FDA: approved

  8. iothalamate sodium i-125

    GLOFIL-125

    INJECTION FDA: approved

  9. iotrolan

    OSMOVIST 240

    INTRATHECAL FDA: approved

  10. ioversol

    OPTIRAY 350

    INJECTION FDA: approved

  11. ioxaglate meglumine

    HEXABRIX

    INJECTION FDA: approved

  12. ioxilan

    OXILAN-350

    INJECTION FDA: approved

  13. ipilimumab

    YERVOY Bristol-Myers Squibb Australia Pty Ltd

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L01FX04
  14. ipodate calcium

    ORAGRAFIN CALCIUM

    ORAL FDA: approved

  15. ipodate sodium

    BILIVIST

    ORAL FDA: approved

  16. ipragliflozin l-proline

    SUGLAT INITIAL APPROVAL

    PMDA: approved

  17. ipratropium

    ATROVENT Cipla Australia Pty Ltd

    TGA: approved

  18. ipratropium bromide

    IPRATROPIUM BROMIDE Amneal Pharma Europe Ltd

    INHALATION FDA: approved

  19. ipsc-derived

    NMPA: clinical trials

  20. iptacopan

    FABHALTA Novartis Pharmaceuticals

    EMA: approved Β· TGA: approved

    L04A
  21. iptacopan hydrochloride

    FABHALTA

    ORAL FDA: approved

  22. iptacopan hydrochloride hydrate

    FABHALTA

    PMDA: approved

  23. ipv

    NMPA: clinical trials

  24. irbd

    NMPA: clinical trials

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources